The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?
Kohl, H.M.; Castillo, A.R.; Ochoa-Repáraz, J. The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease? Diseases 2020, 8, 33. https://doi.org/10.3390/diseases8030033
Kohl HM, Castillo AR, Ochoa-Repáraz J. The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease? Diseases. 2020; 8(3):33. https://doi.org/10.3390/diseases8030033
Chicago/Turabian StyleKohl, Hannah M., Andrea R. Castillo, and Javier Ochoa-Repáraz. 2020. "The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?" Diseases 8, no. 3: 33. https://doi.org/10.3390/diseases8030033